The construction process of Bacillus subtilis strain with multiple mutations is accelerated by simultaneous use of a positive selection method. All the strains selected by neomycin acquired two simultaneous mutations at different genomic loci. The extremely low rate of false positives was accounted for by employing the improved method.
Mutant construction is a central issue for genetics and biotechnology. Bacillus subtilis 168, a gram-positive endospore-forming bacterium, develops competence by which most of the non-essential genes were mutagenized. 1) Isolation of mutants is of great value in the analysis of functionally related genes or genes within the same metabolic pathway. Since these genes are normally dispersed along the genome, an effective method to introduce mutations at multiple loci is needed. The use of two antibiotic resistance markers, referred to as the Gene-Directed Mutagenesis method (GDM), was developed [2] [3] [4] to introduce unlimited numbers of various types of mutations. Although the effectiveness of GDM was fully demonstrated by providing as many as 33-fold mutations, 3) this elaborate method includes a timeconsuming step for screening colonies that are converted to antibiotic sensitive. A positive selection method, hereafter referred to as the cI-Pr method (Fig. 1) , was developed and employed to circumvent that step. This method, using a neomycin resistance gene with Prpromoter (Pr-neo) regulated by presence or absence of the CI repressor binding protein, enabled rapid selection for the unmarked DNA integration process. [5] [6] [7] But careful screening must be carried out to discriminate spontaneous neomycin resistant colonies that appear at frequencies ranging from 10 À5 to 10 À6 due to mutation of the cI gene in the B. subtilis genome (as described in ref. 6 and evident in our unpublished data).
It was expected that the frequency of spontaneous neomycin resistant colonies would be reduced below 10 À10 to 10 À12 if two cI genes were used simultaneously for targeting at two different genomic loci. The two cI gene cassettes, one linked with the spectinomycin resistance gene (cI-spc), and the other with the blasticidin S resistance gene (cI-bsr), were prepared from pBR322-derivative plasmids, pCISP310B (cI-spc) 5, 6) and pBR322CI-BS (cI-bsr) 8) respectively. These two cI genes were used in this study to construct mutants for genes relevant to myo-inositol utilization. 9) Inositol uptake and its degradation are regulated by 12 genes clustered in the iol operon (iolO) located at 4073-4086 kb and two genes, iolU and iolT (iolU/T), at 674-677 kb (Fig. 1) .
Progressive transformation using pGAIN220 and pGAIN156 was done. A cI-spc cassette replaced the 12 genes of the iolO, resulting in BUSY5029. A cI-bsr cassette replaced the iolU/T of BUSY5029, resulting in BUSY5039. The addition of the second cI gene decreased the frequency of spontaneous neomycin-resistant colonies from 3 Â 10 À6 for BUSY5029 to below 10
À12
for BUSY5039 (trpC2 Á(yvfC-yveP)::Pr-neo iolO::cIspc iolU/T::cI-bsr). BUSY5039 contained no neomycinresistant colonies in 1.0 ml of overnight culture (LB media), and did not grow on a myo-inositol agar plate. Nutritional requirements were tested using an M9 plate supplemented with tryptophan (5 mg/ml) and myoinositol (20 mM, 0.4%). These cI cassettes of BUSY5039 were converted to I-CeuI sites by co-transformation with the two fragments, one having the combined flanking sequences for ÁiolO (pGAIN226) and the other having that for ÁiolU/T (pGAIN158). All the 17 colonies selected on LB-agar plate containing neomycin were sensitive to spectinomycin and blasticidin S. Selection conditions for B. subtilis were at 5 mg/ml of neomycin, 50 mg/ml of spectinomycin, and 500 mg/ml of blasticidin S. Preparation and transformation of competent B. subtilis cells were done according to the standard method. 
Note
ÁiolU/T were determined, as shown in Fig. 2A and B. I-CeuI was obtained from New England Biolab (Boston, MA).
The use of the two cI method was examined to create two copies of a gene in the B. subtilis genome. This was performed via the pBR322 sequence already created in the ytqB and proB loci, designated genomic pBR.
3) The cI cassettes in pCISP310B (cI-spc) 5, 6) and pBR322CI-BS (cI-bsr) 8) were directly integrated to these genomic pBR by selection with the linked markers, as shown in Fig. 1 . Strains having a cI cassette integrated at different genomic pBR (ytqB::pBR322 or proB:: pBR322) were separately constructed. They were BEST5892 (ytqB::pBR322CI-BS) and BEST8450 (proB::pCISP310B). BEST5907 was derived from BEST5892 (ytqB::pBR322CI-BS) by transformation using the genome DNA of BEST8450 (proB::pCISP310B). The selection conditions were the same as described above. Two cI genes of BEST5907 completely suppressed spontaneous neomycin-resistant colonies in contrast to the estimated frequency 10 À6 of BEST5892 and BEST8450. Replacement of these cI genes by a phleomycin resistance gene (phl) was examined using pBRphl, a pBR322-based plasmid. The antibiotic resistance gene phl (ble) encoded by the pUB110 plasmid at nucleotide positions 1,034 to 2,366 was amplified by PCR-mediated cloning and subcloned in pBR322, resulting in pBRphl. pBRphl has two I-SceI sites (recognition sequence: 5 0 -TAGGGATAACAGGG-TAAT-3 0 ) at the both end of phl gene as a physical landmark. Only cells in which two cI genes are simultaneously replaced were expected to become neomycin-resistant. Four colonies isolated using 1 mg pBRphl were all sensitive to spectinomycin and blasticidin S, and resistant to phleomycin at 0.5 mg/ml. The local structure of the two genomic pBRs of one representative BEST5918 (RM125: Á(yvfC-yveP):: Pr-neo proB::pBRphl ytqB::pBRphl) was confirmed by Southern hybridization (data not shown). The locations of the two newly introduced I-SceI sites were confirmed by expected 2,472 and 1,742 kb fragments given from BEST5918 ( Fig. 2A and C) . I-SceI was purchased from Roche (Mannheim, Germany).
The results of this study indicated that a combinatorial use of the two cI-Pr method allows simultaneous targeting of two unlinked genetic loci of B. subtilis. Repeated use of the method would create more number of mutations in the genome efficiently. Fig. 1 and Fig. 2A ) produced four additional I-CeuI fragments, indicated by arrowheads with their sizes. Running conditions: 1% agarose, TBE (14 C), 45 sec pulse time, 3 V cm À1 , and 42 h running time. Concatemeric lambda DNA as size markers with their sizes are to the left. (C) Two I-SceI fragments generated from strain BEST5918. Running conditions are the same as in (B) except for 8-min pulse time, and 72 h running time to obtain higher resolution above 300 kb. The genome of Saccharomyces cerevisiae was used as a size marker (purchased from Bio-Rad Laboratories, Hercules, CA) with their sizes at the left.
